Five prognostic genes, including HPSE, DENND1C, GRWD1, HLA‐DQA1, and PDXK, were identified to further develop a risk signature, which exhibited moderate power for forecasting the prognosis of lung cancer patients in training, testing, and validation sets. This evidence concerns the gene GRWD1 and lung carcinoma.